The data will help to provide enhanced insight into the testing landscape for precision medicine through Diaceutics’ DXRX diagnostic commercialisation platform. The increased frequency of data feed will will help Diaceutics’s pharma and diagnostic clients to understand the evolving testing landscape in almost real time, which should help drive faster access to the right treatment.said the step up in data access would help “supercharge” its service in the market.
“The most competitive companies in the diagnostic data space are those that not only can integrate very different large data sets but can deliver near real time customer insights,” he said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: